Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MTX clearance is more important for intermediate-risk ALL

W E Evans, M J Schell, C H Pui

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |June 1, 1990
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors.

    ESMO open·2024
    Same author

    Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors.

    Bone marrow transplantation·2016
    Same author

    Pre-B-Cell Acute Lymphoblastic Leukemia in Childhood.

    Leukemia & lymphoma·2016
    Same author

    Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors.

    Endocrine-related cancer·2014
    Same author

    A revised definition for cure of childhood acute lymphoblastic leukemia.

    Leukemia·2014
    Same author

    Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase.

    Cancer chemotherapy and pharmacology·2014